167 related articles for article (PubMed ID: 20625970)
1. Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats.
Miura K; Kitahara Y; Yamagishi S
Horm Metab Res; 2010 Sep; 42(10):731-5. PubMed ID: 20625970
[TBL] [Abstract][Full Text] [Related]
2. Potential utility of combination therapy with nateglinide and telmisartan for metabolic derangements in Zucker Fatty rats.
Kajioka T; Miura K; Kitahara Y; Yamagishi S
Horm Metab Res; 2007 Dec; 39(12):889-93. PubMed ID: 17987547
[TBL] [Abstract][Full Text] [Related]
3. Nateglinide suppresses postprandial hypertriglyceridemia in Zucker fatty rats and Goto-Kakizaki rats: comparison with voglibose and glibenclamide.
Mine T; Miura K; Kitahara Y; Okano A; Kawamori R
Biol Pharm Bull; 2002 Nov; 25(11):1412-6. PubMed ID: 12419950
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation.
McKillop AM; Duffy NA; Lindsay JR; Green BD; Patterson S; O'Harte FP; Bell PM; Flatt PR
Eur J Endocrinol; 2009 Dec; 161(6):877-85. PubMed ID: 19755410
[TBL] [Abstract][Full Text] [Related]
5. Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
Breitschaft A; Hu K; Hermosillo Reséndiz K; Darstein C; Golor G
Diabetes Res Clin Pract; 2014 Mar; 103(3):458-65. PubMed ID: 24461109
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Miyagawa K; Kondo T; Goto R; Matsuyama R; Ono K; Kitano S; Kawasaki S; Igata M; Kawashima J; Matsumura T; Motoshima H; Araki E
Cardiovasc Diabetol; 2013 Nov; 12():160. PubMed ID: 24188631
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
[TBL] [Abstract][Full Text] [Related]
8. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A
Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639
[TBL] [Abstract][Full Text] [Related]
9. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
[TBL] [Abstract][Full Text] [Related]
10. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
Mine T; Miura K; Kajioka T; Kitahara Y
Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes.
Dalla Man C; Bock G; Giesler PD; Serra DB; Ligueros Saylan M; Foley JE; Camilleri M; Toffolo G; Cobelli C; Rizza RA; Vella A
Diabetes Care; 2009 Jan; 32(1):14-8. PubMed ID: 18931099
[TBL] [Abstract][Full Text] [Related]
12. Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients.
Voytovich MH; Haukereid C; Hjelmesaeth J; Hartmann A; Løvik A; Jenssen T
Clin Transplant; 2007; 21(2):246-51. PubMed ID: 17425753
[TBL] [Abstract][Full Text] [Related]
13. Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
Br J Pharmacol; 2013 Jul; 169(5):1048-57. PubMed ID: 23488656
[TBL] [Abstract][Full Text] [Related]
14. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S; Sole S
Eur J Pharm Sci; 2012 Sep; 47(2):456-63. PubMed ID: 22800967
[TBL] [Abstract][Full Text] [Related]
15. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.
Utzschneider KM; Tong J; Montgomery B; Udayasankar J; Gerchman F; Marcovina SM; Watson CE; Ligueros-Saylan MA; Foley JE; Holst JJ; Deacon CF; Kahn SE
Diabetes Care; 2008 Jan; 31(1):108-13. PubMed ID: 17909087
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes.
Kalra S
J Assoc Physicians India; 2011 Apr; 59():237-45. PubMed ID: 21755761
[TBL] [Abstract][Full Text] [Related]
17. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance.
Ittichaicharoen J; Apaijai N; Tanajak P; Sa-Nguanmoo P; Chattipakorn N; Chattipakorn S
Arch Oral Biol; 2018 Jan; 85():148-153. PubMed ID: 29073562
[TBL] [Abstract][Full Text] [Related]
19. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.
Ávila Dde L; Araújo GR; Silva M; Miranda PH; Diniz MF; Pedrosa ML; Silva ME; de Lima WG; Costa DC
Arch Med Res; 2013 Apr; 44(3):194-202. PubMed ID: 23523961
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.
Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
Endocrinology; 2012 Aug; 153(8):3878-85. PubMed ID: 22621958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
